<DOC>
	<DOC>NCT01541748</DOC>
	<brief_summary>This study is a prospective, single arm, multi-center, post-market study to evaluate the efficacy of Axis™ Allograft Dermis used for anterior, posterior or combined (anterior and posterior) pelvic organ prolapse repair.</brief_summary>
	<brief_title>Axis™ Allograft Dermis for Female Pelvic Floor Repair: a Prospective Post Market Study</brief_title>
	<detailed_description />
	<mesh_term>Prolapse</mesh_term>
	<mesh_term>Pelvic Organ Prolapse</mesh_term>
	<criteria>Adult female at least 18 years of age. Willing and able to provide written informed consent. Confirmed pelvic organ prolapse (POP) of Stage 2 or higher as determined by POPQ prolapse grading requiring surgical intervention in the anterior, posterior or combined (anterior and posterior) compartment. Willing and able to complete all followup visits and procedures indicated in this protocol. Concurrent surgical treatment of pelvic organ prolapse using anything other than the Axis Dermis.[Note: concurrent midurethral sling placement for treatment of stress urinary incontinence is allowed]. Confirmed Stage 2 or higher prolapse as determined by POPQ prolapse grading for a compartment that is not being repaired in the same procedure. (Concurrent POPQ Stage 1 repair is at the physician's discretion.) Previous pelvic organ prolapse repair using biologic, or synthetic grafts. [Note: previous midurethral sling for treatment of stress urinary incontinence is allowed] Pregnant or a desire to become pregnant in the future. Previous radiation or other treatments for cancer in the pelvic area. Severe urogenital atrophy. Immunosuppression and/or current systemic steroid user. Any contraindication to the surgical procedure.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>